Acute Coronary Syndromes Clinical Trials

41 recruitingLast updated: June 18, 2026

There are 41 actively recruiting acute coronary syndromes clinical trials across 28 countries. Studies span Not Applicable, Phase 4, Phase 3, Early Phase 1, Phase 1, Phase 2. Top locations include El Palmar, Murcia, Spain, Shanghai, Shanghai Municipality, China, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Acute Coronary Syndromes Trials at a Glance

41 actively recruiting trials for acute coronary syndromes are listed on ClinicalTrialsFinder across 6 cities in 28 countries. The largest study group is Not Applicable with 15 trials, with the heaviest enrollment activity in El Palmar, Shanghai, and Barcelona. Lead sponsors running acute coronary syndromes studies include Ruijin Hospital, SUK MIN SEO, and Acibadem University.

Browse acute coronary syndromes trials by phase

Treatments under study

About Acute Coronary Syndromes Clinical Trials

Looking for clinical trials for Acute Coronary Syndromes? There are currently 30 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Acute Coronary Syndromes trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Acute Coronary Syndromes clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 41 trials

Recruiting
Not Applicable

Oregano and Basil Leaves and Coronary Artery Disease

Acute Coronary SyndromesUnstable Angina (UA)
Shahid Beheshti University of Medical Sciences70 enrolled1 locationNCT07123181
Recruiting
Phase 1

The Pharmacokinetics and Pharmacodynamics Study of CG-0255 Besylate and Plavix® in Healthy Participants

Peripheral Arterial DiseaseRecent Myocardial InfarctionRecent Stroke+1 more
Shanghai CureGene Pharmaceutical Co., Ltd.136 enrolled1 locationNCT07619885
Recruiting
Phase 3

Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination

PneumoniaCOPD, Chronic Obstructive Pulmonary Diseaseacute coronary syndromes (ACS)
University of Brawijaya60 enrolled1 locationNCT07604103
Recruiting
Not Applicable

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease

intermittent claudicationstable coronary artery diseaseAcute Coronary Syndromes+1 more
Maria Cecilia Hospital60 enrolled1 locationNCT07588295
Recruiting
Phase 3

Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.

Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndromes+3 more
Cardiocentro Ticino355 enrolled1 locationNCT07582835
Recruiting
Phase 4

Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia

Coronary Artery EctasiaSTEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)+1 more
Instituto Nacional de Cardiologia Ignacio Chavez326 enrolled1 locationNCT07511257
Recruiting
Not Applicable

Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy

Coronary Artery Disease (CAD)acute coronary syndromes (ACS)
SUK MIN SEO400 enrolled1 locationNCT07479056
Recruiting
Not Applicable

IVUS-Guided vs Angiography-Guided PCI in Acute Coronary Syndrome

acute coronary syndromes (ACS)
SUK MIN SEO1,500 enrolled1 locationNCT07512778
Recruiting
Phase 4

Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome

Elderly (People Aged 65 or More)Iron Deficienciesacute coronary syndromes (ACS)
Fundación para la Investigación del Hospital Clínico de Valencia538 enrolled9 locationsNCT07476859
Recruiting
Not Applicable

Point-of-Care Troponin Testing in the Emergency Department

Acute Coronary Syndromes
KU Leuven1,552 enrolled1 locationNCT06845826
Recruiting

A Prospective, Single-center, Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes, Combined With Echocardiographic and Biochemical Indices

Endothelial Function (FMD)Acute Coronary SyndromesFlow Mediated Dilation
Aristotle University Of Thessaloniki100 enrolled1 locationNCT06890013
Recruiting
Early Phase 1

Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients

Atherosclerotic Cardiovascular DiseaseAcute Coronary Syndromes
Cyclarity Therapeutics, Inc.84 enrolled1 locationNCT06813339
Recruiting
Not Applicable

Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.

acute coronary syndromes (ACS)
Casa di Cura Dott. Pederzoli15 enrolled1 locationNCT07429227
Recruiting
Phase 2

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

Heart DiseaseInflammationCoronary Arterial Disease (CAD)+3 more
Abcentra240 enrolled41 locationsNCT06927739
Recruiting
Not Applicable

Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques

Cardiovascular DiseaseCoronary Artery DiseaseAtheroscleroses+4 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)400 enrolled1 locationNCT07107971
Recruiting
Not Applicable

Influenza Vaccination After Acute Coronary Syndrome

acute coronary syndromes (ACS)
Tongji Hospital6,620 enrolled1 locationNCT07259252
Recruiting
Not Applicable

One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care

Primary CareChest PainAcute Myocardial Infarction (AMI)+5 more
University of Oslo2,500 enrolled6 locationsNCT06853626
Recruiting
Not Applicable

Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

DyspneaAcute Coronary SyndromesTicagrelor
Acibadem University110 enrolled2 locationsNCT07268859
Recruiting
Phase 4

Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques

Coronary Arterial Disease (CAD)Vulnerable Coronary PlaquesThin-cap fIbroatheroma+1 more
Beijing Anzhen Hospital2,190 enrolled1 locationNCT06855537
Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions

Myocardial IschemiaCoronary Artery DiseaseIschemic Heart Disease+3 more
Biotronik AG100 enrolled8 locationsNCT07091682